Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - SELECT MEDICAL HOLDINGS CORP | w81669e10vk.htm |
| EX-23 - EX-23 - SELECT MEDICAL HOLDINGS CORP | w81669exv23.htm |
| EX-12 - EX-12 - SELECT MEDICAL HOLDINGS CORP | w81669exv12.htm |
| EX-31.1 - EX-31.1 - SELECT MEDICAL HOLDINGS CORP | w81669exv31w1.htm |
| EX-21.1 - EX-21.1 - SELECT MEDICAL HOLDINGS CORP | w81669exv21w1.htm |
| EX-31.2 - EX-31.2 - SELECT MEDICAL HOLDINGS CORP | w81669exv31w2.htm |
| EX-10.115 - EX-10.115 - SELECT MEDICAL HOLDINGS CORP | w81669exv10w115.htm |
| EX-10.112 - EX-10.112 - SELECT MEDICAL HOLDINGS CORP | w81669exv10w112.htm |
| EX-10.114 - EX-10.114 - SELECT MEDICAL HOLDINGS CORP | w81669exv10w114.htm |
| EX-10.113 - EX-10.113 - SELECT MEDICAL HOLDINGS CORP | w81669exv10w113.htm |
| EX-10.111 - EX-10.111 - SELECT MEDICAL HOLDINGS CORP | w81669exv10w111.htm |
| EX-10.117 - EX-10.117 - SELECT MEDICAL HOLDINGS CORP | w81669exv10w117.htm |
| EX-10.116 - EX-10.116 - SELECT MEDICAL HOLDINGS CORP | w81669exv10w116.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Select Medical Holdings Corporation and Select
Medical Corporation (the “Company”) for the period ended December 31, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), we, Robert A. Ortenzio and
Martin F. Jackson, Chief Executive Officer and Chief Financial Officer, respectively, of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to our knowledge:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | ||
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report. |
March 9, 2011
/s/ Robert A. Ortenzio
|
||
Chief Executive Officer |
||
/s/ Martin F. Jackson
|
||
Executive Vice President and Chief Financial
Officer |